COV002

COVID-19 Phase II/III Vaccine Study(English)

  • a continuing single-blind phase 2/3 study in the UK that began on May 28, 2020, and enrolled participants in 19 study sites in England, Wales, and Scotland. Enrolment particularly targeted individuals working in professions with high possible exposure to SARS-CoV-2, such as health and social care settings
  • COVID-19
  • Clinical trials, Vaccination
  • https://clinica…how/NCT04400838